Bayer EBIT 2012-2025 | BAYRY

Bayer EBIT for the quarter ending December 31, 2025 was $-3.047B, a 269.43% decline year-over-year.

  • Bayer 2025 EBIT was -1.219B, a 1485.95% increase from 2024.
  • Bayer 2024 EBIT was -0.077B, a 111.6% decline from 2023.
  • Bayer 2023 EBIT was 0.662B, a 91.03% decline from 2022.

EBIT can be defined as earnings before interest and taxes.

Bayer EBIT 2012-2025 | BAYRY

  • Bayer 2025 EBIT was -1.219B, a 1485.95% increase from 2024.
  • Bayer 2024 EBIT was -0.077B, a 111.6% decline from 2023.
  • Bayer 2023 EBIT was 0.662B, a 91.03% decline from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B